Singapore Press says shareholders approve acquisition by Cuscaden Peak -Breaking
[ad_1]
© Reuters. FILEPHOTO: This is a view of Singapore Press Holdings Ltd’s (SPH) offices in Singapore on November 3, 2021. REUTERS/Caroline ChiaSINGAPORE (Reuters) Singapore Press Holdings, or SPH for short, announced on Tuesday that shareholders have approved Cuscaden Peak acquisition. The announcement came after Keppel had been terminated (OTC:) Corp).
Keppel Corp, Cuscaden Peak, and Temasek are connected to each other. This deal has sparked rare bidding wars between both groups. Keppel Corp offered S$2.40 per Share, S$3.9 Billion ($2.87 Billion), while Keppel Corp was offering S$2.351 Per Share, S$3.74Billion, for SPH’s Real Estate business.
Keppel Corp is a major shareholder of Temasek Holdings. It previously stated that it didn’t agree with SPH’s decision to end its offer. A notice of arbitration was filed by the conglomerate with Singapore International Arbitration Centre.
Cuscaden Peak was a joint venture of Ong Beng Seng (property tycoon)’s Hotel Properties, as well as two independent portfolio companies managed by Temasek. The acquisition has been completed, SPH stated in a statement. SPH will grant it access to its real estate portfolio that includes shopping malls, residences and student accommodation. It won’t have the loss-making media company, however.
Cuscaden will be reviewed by the Singapore Court around April 5th. Shareholders should expect to begin receiving payments in May 11th, SPH stated.
SPH was also granted permission by Singapore Exchange (OTC) to not announce its financial results for the first half year. However, shareholder approval is required.
($1 = 1.3578 Singapore dollars)
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]
